M
McKesson Europe AG
XHAM:CLS1
McKesson Europe AG
XHAM:CLS1
Price:
24.4 EUR
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of CLS1.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLS1
Relative Value
Base Case
Not Available
M
Valuation Multiples
Multiples Across Competitors
CLS1 Competitors Multiples
McKesson Europe AG Competitors
McKesson Europe AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
71.2B USD | 0.2 | 23.7 | 16.5 | 19.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
48B USD | 0.2 | 25.7 | 13.2 | 18.5 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
25.2B USD | 0.1 | 39.4 | 8.8 | 11.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 0.8 | 22.7 | 11.9 | 16 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.3B HKD | 0.1 | 7 | 1.7 | 2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.5B CNY | 1.4 | 21.4 | 15.5 | 15.5 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.1 | 45.9 | 14.8 | 29.2 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.8B CNY | 0.2 | 13.5 | 8 | 8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
